Found 43 matching trials
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
N/AThis observational study aims to identify genes that may affect how patient...
Location
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
PHASE4Background:
* Rheumatoid arthritis (RA) is often treated with drugs known ...
Location
Georgetown University Medical Center
Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence
NAStudy comparing 2 modalities of Crohn's disease patients postoperative foll...
Location
CHU de Montpellier
Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD
PHASE4To examine whether a temporary three month increase in adalimumab dosing wi...
Location
Multiple Locations
Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
PHASE4Rheumatoid arthritis (RA) is the most common inflammatory joint disorder. S...
Location
Infirmerie Protestante
Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis
NAThis is a multi-center, prospective, randomized controlled non-inferior cli...
Status
Active Not Recruiting
Location
Shenzhen Eye Hospital
Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease
PHASE3This study will evaluate higher versus standard adalimumab dosing regimens ...
Location
Birmingham Gastroenterology Associates O.C /ID# 137282
Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
PHASE4Patients with ulcerative colitis (UC), a chronic inflammatory bowel disease...
Location
Boston Medical Center
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
N/AThe aim of this study is to determine the impact of systemic immunosuppress...
Location
Mayo Clinic Jacksonville, FL
A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated
PHASE4Recently, the optimal therapeutic serum trough level range of adalimumab wa...
Location
University Hospital